Point of Care Ultrasonography

Soroka University Medical Center60 enrolled

Overview

This is a Prospective, Double-center, randomized clinical trial. The purpose of the trial is to evaluate the benefit of adding POC US to the management of inpatients admitted to the internal ward with respiratory, cardiovascular or hemodynamic abnormalities. This is a stage 1 pilot trial aimed to provide better understanding on the study population and study groups. This trial will comprise a total of 60 patients, 30 subjects on the intervention group and an equal number on the control group. The results of this pilot trial will be to design a larger trial and calculate a required sample size.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Respiratory Abnormalities Cardiovascular Abnormalities Hemodynamic Instability

Interventions

Point Of Care UltrasoundDEVICE

Examination with an ultrasound machine

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients admitted to internal ward 2. Age ≥ 18 3. No previous internal ward admission within the last 6 months 4. At least one symptom or sign of the following on admission: * Respiratory abnormalities: Dyspnea, RR\>20, O2 SAT\<90% requirement of oxygen or non-invasive ventilation or mechanical ventilation * Cardiovascular abnormalities: Chest pain, HR\>100, new/worsening peripheral edema, newly diagnosed ECG changes * Hemodynamic instability: SBP\<90 mmHg or on vasopressor infusion or pre-renal azotemia Exclusion Criteria: 1. Patients with cognitive impairment or cannot sign informed consent. 2. Subject enrolled in a different study 3. Patients with end stage disease receiving Palliative/end of life treatments. 4. Pregnant patients. 5. Patients that were given a consult by one of the research members pre enrollment 6. Patient under responsibility of one of the study team members

Locations (1)

Soroka University Medical Center

Beersheba, Israel

Outcomes

Primary Outcomes

Length of hospitalization

Time frame: 1 month

Secondary Outcomes

Readmission rates

Time frame: 15 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.